Title:
FUSION PROTEIN AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/094119
Kind Code:
A1
Abstract:
The present invention relates to a fusion protein, which comprises an anti-T cell surface molecular antibody, interleukin 2, and immunoglobulin Fc. The fusion protein is a heterodimer or a homodimer. The present invention further relates to use of the fusion protein in the preparation of an anti-tumor drug.
More Like This:
| WO/2000/072010 | USE OF AN ANTIBODY TO DETECT BASOPHILES AND/OR MAST CELLS |
| WO/2014/076292 | RECOMBINANT BISPECIFIC ANTIBODY BINDING TO CD20 AND CD95 |
| WO/1999/035283 | METHODS AND REAGENTS FOR MODULATING CELL MOTILITY |
Inventors:
FU YANGXIN (CN)
REN ZHENHUA (CN)
REN ZHENHUA (CN)
Application Number:
PCT/CN2023/129321
Publication Date:
May 10, 2024
Filing Date:
November 02, 2023
Export Citation:
Assignee:
BEIJING CHANGPING LABORATORY (CN)
International Classes:
C07K16/28; A61K39/395; A61P35/00; C07K14/54; C07K14/715
Domestic Patent References:
| WO2017218707A2 | 2017-12-21 | |||
| WO2020259536A1 | 2020-12-30 |
Foreign References:
| CN113423734A | 2021-09-21 | |||
| CN110382525A | 2019-10-25 | |||
| CN112771072A | 2021-05-07 | |||
| CN113248613A | 2021-08-13 | |||
| CN110256583A | 2019-09-20 | |||
| CN109069570A | 2018-12-21 | |||
| CN111050791A | 2020-04-21 | |||
| CN111635460A | 2020-09-08 | |||
| CN113501880A | 2021-10-15 | |||
| CN115232797A | 2022-10-25 |
Attorney, Agent or Firm:
CHINA SCIENCE PATENT & TRADEMARK AGENT LTD. (CN)
Download PDF: